Clinical Trial Update: Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial comparing family-mismatched/haploidentical donors to matched unrelated donors in acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Byung-Sik Cho | Conditions: Acute Myeloid Leukemia | Phase 2, Phase 3 | Status: COMPLETED